Profile

Alan C. Farney, M.D.Wake Forest Baptist Health

Doctor Rating

4.7 out of 5

54 Ratings
7 Comments
 

Alan C. Farney, M.D.

Professor, Surgical Sciences-Transplant

Clinical Interests

Kidney Transplantation, Pancreas Transplantation

Contact Information

New Patient Appointments: 336-716-WAKE
Returning Patient Appointments: 336-716-0548
Department: 336-716-6371

Email: afarney@wakehealth.edu

Insurance Accepted »

Education & Training

  • B.A., Haverford College, 1983
  • M.D., University of Rochester Sch of Med & Dentistry, 1987
  • Internship, U Minnesota Hosps & Clins, 1988
  • Residency, U Minnesota Hosps & Clins, 1990
  • Fellowship, U Minnesota Hosps & Clins, 1991
  • Fellowship, University of Minnesota Medica, 1993
  • Residency, U Minnesota Hosps & Clins, 1994
  • Residency, U Minnesota Hosps & Clins, 1995
  • Fellowship, U Minnesota Hosps & Clins, 1997

Board Certifications

  • American Board of Surgery, Surgery

NPI Number

  • 1518942648
Alan C. Farney, M.D.

Doctor Rating

4.7 out of 5

54 Ratings
7 Comments
 

Alan C. Farney, M.D.

Professor, Surgical Sciences-Transplant
Institute for Regenerative Medicine

Research Interests

Kidney Transplantation; Pancreas Transplantation; Graft Rejection; Tissue Donors; Immunosuppressive Agents
More »

Contact Information

Academic: 336-716-6371 | Department: 336-716-6371

Email: afarney@wakehealth.edu

Recent Publications

Evolution of islet transplantation for the last 30 years. Farney AC, Sutherland DE, Opara EC.. Pancreas. 2016;45(1):8-20.

Kidney transplantation, bioengineering and regeneration: an originally immunology-based discipline destined to transition towards ad hoc organ manufacturing and repair. Rogers J, Katari R, Gifford S, Tamburrini R, Edgar L, Voigt MR, Murphy SV, Igel D, Mancone S, Callese T, Colucci N, Mirzazadeh M, Peloso A, Zambon JP, Farney AC, Stratta RJ, Orlando G.. Expert Rev Clin Immunol. 2016;12(2):169-182.

A double-blind, double-dummy, flexible-design randomized multicenter trial: early safety of single- versus divided-dose rabbit anti-thymocyte gobulin induction in renal transplantation. Stevens RB, Wrenshall LE, Miles CD, Farney AC, Jie T, Sandoz JP, Rigley TH, Gaber AO.. Am J Transplant. 2016;16(6):1858-1867.

The human pancreas as a source of protolerogenic extracellular matrix scaffold for a new-generation bioartificial endocrine pancreas. Peloso A, Urbani L, Cravedi P, Katari R, Maghsoudlou P, Fallas ME, Sordi V, Citro A, Purroy C, Niu G, McQuilling JP, Sittadjody S, Farney AC, Iskandar SS, Zambon JP, Rogers J, Stratta RJ, Opara EC, Piemonti L, Furdui CM, Soker S, De Coppi P, Orlando G.. Ann Surg. 2016;264(1):169-179.

APOL1 genotype and kidney transplantation outcomes from deceased African American donors. Freedman BI, Pastan SO, Israni AK, Schladt D, Julian BA, Gautreaux MD, Hauptfeld V, Bray RA, Gebel HM, Kirk AD, Gaston RS, Rogers J, Farney AC, Orlando G, Stratta RJ, Mohan S, Ma L, Langefeld CD, Bowden DW, Hicks PJ, Palmer ND,.. Transplantation. 2016;100(1):194-202.

Is prolonged cold ischemia a contraindication to using kidneys from acute kidney injury donors? [abstract]. Carrier A, Kahn MA, El-Hennawy H, Farney A, Rogers J, Orlando G, Stratta R.. Am J Transplant. 2016;16(Suppl 1):43.

Eversion endarterectomy of the deceased donor renal artery to prevent kidney discard [abstract]. Jones K, Khan A, El-Hennawy H, Farney A, Rogers J, Orlando G, Stratta R.. Am J Transplant. 2016;16(Suppl 1):44.

Differential effect of delayed graft function on kidney transplant outcomes [abstract]. Khan M, El-Hennawy H, Farney A, Rogers J, Orlando G, Brim E, Hairston G, Mangus M, Stratta R.. Am J Transplant. 2016;16(Suppl 1):53.

Analysis of local versus imported expanded criteria donor (ECD) kidneys: a single center experience with 497 ECD kidney transplants [abstract]. Khan M, El-Hennawy H, Rogers J, Farney A, Orlando G, Palanisamy A, Reeves-Daniel A, Stratta R.. Am J Transplant. 2016;16(Suppl 1):54.

Dual kidney transplants from adult marginal donors successfully expand the limited deceased donor organ pool. Stratta RJ, Farney AC, Orlando G, Farooq U, Al-Shraideh Y, Palanisamy A, Reeves-Daniel A, Doares W, Kaczmorski S, Gautreaux MD, Iskandar SS, Hairston G, Brim E, Mangus M, El-Hennawy H, Khan M, Rogers J.. Clin Transplant. 2016;30(4):380-392.

Single vs dual (en bloc) kidney transplants from donors less than or equal to 5 years of age: a single center experience. Al-Shraideh Y, Farooq U, El-Hennawy H, Farney AC, Palanisamy A, Rogers J, Orlando G, Khan M, Reeves-Daniel A, Doares W, Kaczmorski S, Gautreaux MD, Iskandar SS, Hairston G, Brim E, Mangus M, Stratta RJ.. World J Transplant. 2016;6(1):239-248.

Role of allograft nephrectomy following kidney graft failure: preliminary experience with pre-operative angiographic kidney embolization. Al-Geizawi SM, Singh RP, Zuckerman JM, Requarth JA, Farney AC, Rogers J, Taussig J, Orlando G, Stratta RJ.. J Nephrol. 2015;28(3):379-385.

Simultaneous transplantation of the living donor kidney and deceased donor pancreas and other transplant options for diabetic and uremic patients. Farney AC, Rogers J, Orlando G, Stratta RJ.. Curr Opin Organ Transplant. 2015;20(1):103-107.

Does prolonged cold ischemia influence outcomes following pancreas transplantation? [abstract]. El Hennawy H, Rogers J, Farney A, Orlando G, Kahn M, Reeves-Daniel A, Palanisamy A, Stratta R.. Am J Transplant. 2015;15(Suppl 1):112.

Analysis of local versus imported expanded criteria donor (ECD) kidneys: a single center experience with 497 ECD kidney transplants [abstract]. El Hennawy H, Farney A, Orlando G, Rogers J, Khan M, Reeves-Daniel A, Palanisamy A, Gautreaux M, Iskandar S, Doares W, Kaczmorski S, Mangus M, Stratta R.. Am J Transplant. 2015;15(Suppl 1):75.

Prospect for kidney bioengineering: shortcomings of the status quo. Peloso A, Katari R, Murphy SV, Zambon JP, DeFrancesco A, Farney AC, Rogers J, Stratta RJ, Manzia TM, Orlando G.. Expert Opin Biol Ther. 2015;15(4):547-558.

Discarded human pancreas as source of ECM scaffold for a new generation bio-artificial endocrine pancreas [abstract]. Peloso A, Katari R, Urbani L, Maghsoudlou P, Fallas MEA, Citro A, Delario G, Willis C, Farney A, Rogers J, Stratta R, Peimonti L, Soker S, Orlando G.. Am J Transplant. 2015;15(Suppl 1):49.

Pancreas transplantation in C-peptide positive patients: does 'type' of diabetes really matter?. Stratta RJ, Rogers J, Farney AC, Orlando G, El-Hennawy H, Gautreaux MD, Reeves-Daniel A, Palanisamy A, Iskandar SS, Bodner JK.. J Am Coll Cardiol. 2015;220(4):716-727.

Apolipoprotein L1 gene variants in deceased organ donors are associated with renal allograft failure. Freedman BI, Julian BA, Pastan SO, Israni AK, Schladt D, Gautreaux MD, Hauptfeld V, Bray RA, Gebel HM, Kirk AD, Gaston RS, Rogers J, Farney AC, Orlando G, Stratta RJ, Mohan S, Ma L, Langefeld CD, Hicks PJ, Palmer ND, Adams PL,.. Am J Transplant. 2015;15(6):1615-1622.

Deceased donor multidrug resistance protein 1 and caveolin 1 gene variants may influence allograft survival in kidney transplantation. Ma J, Divers J, Palmer ND, Julian BA, Israni AK, Schladt D, Pastan SO, Chattrabhuti K, Gautreaux MD, Hauptfeld V, Bray RA, Kirk AD, Brown WM, Gaston RS, Rogers J, Farney AC, Orlando G, Stratta RJ, Guan M, Palanisamy A, Reeves-Daniel AM, Bowden DW,.. Kidney Int. 2015;88(3):584-592.

Donor-derived myeloid sarcoma in two kidney transplant recipients from a single donor. Palanisamy A, Persad P, Koty PP, Douglas LL, Stratta RJ, Rogers J, Reeves-Daniel AM, Orlando G, Farney AC, Beaty MW, Pettenati MJ, Iskandar SS, Grier DD, Kaczmorski SA, Doares WH, Gautreaux MD, Freedman BI, Powell BL.. Case Rep Nephrol. 2015;2015():821346.

The human pancreas as a source of pro-tolerogenic extracellular matrix scaffold for a new generation bio-artificial endocrine pancreas [abstract]. Peloso A, Orlando G, Urbani L, Cravedi P, Sordi V, Guoguang N, Citro A, Mcquilling J, Farney A, Iskandar S, Rogers J, Stratta R, Opara E, Piemonti L, Soker S, De Coppi P, Petrosyan A.. Tissue Eng Part A. 2015;21(Suppl 1):S141.

The human pancreas as a source of protolerogenic extracellular matrix scaffold for a new generation bioartificial endocrine pancreas [abstract]. Orlando G, Peloso A, Urbani L, Cravedi P, Katari R, Maghsoudlou P, Fallas EMA, Sordi V, Purroy C, Niu GG, Mcquilling JP, Sivanandane S, Farney AC, Iskandar SS, Rogers J, Stratta RJ, Opara EC, Piemonti L, Soker S, De Coppi P.. Transpl Int. 2015;28(Suppl 4):129.

Analysis of patient refusals for transplantation [abstract]. Reeves-Daniel A, Palanisamy A, Orlando G, Rogers J, Russell G, Farney A, Burkart J, Stratta R, Freedman B.. Am J Transplant. 2015;15(Suppl 3):1761.

Import pancreas transplants: good from far or far from good? [abstract]. Rogers J, Farney A, Orlando G, Reeves-Daniel A, Palanisamy A, El-Hennawy H, Khan M, Gautreaux M, Iskandar S, Stratta R.. Am J Transplant. 2015;15(Suppl 3):1068.

Pancreas transplantation with portal venous drainage with an emphasis on technical aspects. Rogers J, Farney AC, Orlando G, Farooq U, Al-Shraideh Y, Stratta RJ.. Clin Transplant. 2014;28(1):16-26.

Single versus dual (en bloc) kidney transplants from donors less than 5 years of age: a single center experience [abstract]. Al-Shraideh Y, Farney A, Rogers J, Orlando G, Farooq U, Stratta R.. Am J Transplant. 2014;14(Suppl 2):72.

Is recipient BMI greater than or equal to 40 a contraindication to kidney transplantation? [abstract]. Farooq U, Alshraideh Y, Orlando G, Rogers J, Farney A, Stratta R.. Am J Transplant. 2014;14(Suppl 2):74-75.

Effect of donor obesity on outcomes in expanded criteria donor kidney transplantation [abstract]. Farooq U, Alshraideh Y, Orlando G, Rogers J, Farney A, Stratta R.. Am J Transplant. 2014;14(Suppl 2):74.

Does high recipient BMI influence outcomes in deceased donor kidney transplantation? A paired donor kidney analysis [abstract]. Farooq U, Alshraideh Y, Orlando G, Rogers J, Farney A, Stratta R.. Am J Transplant. 2014;14(Suppl 2):74.

Immunosuppression for pancreas transplantation with an emphasis on antibody induction strategies: review and perspective. Stratta RJ, Farney AC, Rogers J, Orlando G.. Expert Rev Clin Immunol. 2014;10(1):117-132.

Influence of prolonged cold ischemia in the era of marginal donor utilization [abstract]. Al-Shraideh Y, Farney A, Rogers J, Orlando G, Farooq U, Stratta R.. Am J Transplant. 2014;14(Suppl 2):72.

Successful unintentional ABO-incompatible renal transplantation: blood group A1B donor into an A2B recipient. Fadeyi EA, Stratta RJ, Farney AC, Pomper GJ.. Am J Clin Pathol. 2014;141(5):724-726.

Long-term function of islets encapsulated in a redesigned alginate microcapsule construct in omentum pouches of immune-competent diabetic rats. Pareta R, McQuilling JP, Sittadjody S, Jenkins R, Bowden S, Orlando G, Farney AC, Brey EM, Opara EC.. Pancreas. 2014;43(4):605-613.

Primary non function after deceased donor kidney transplantation: risks and consequences [abstract]. Al-Shraideh Y, Stratta R, Farney A, Orlando G, Palanisamy A, Reeves-Daniel A, Bodner J, Uloko V, Winfrey S, Kaczmorski S, Doares W, Mangus M, Gautreaux M, Iskandar S, Rogers J.. Transplantation. 2014;98(Suppl 1):631.

Single center analysis of outcomes in 202 consecutive pancreas transplants according to different measures of success [abstract]. Bodner J, Farney A, Rogers J, Orlando G, Farooq U, Al-Shraideh Y, Reeves-Daniel A, Palanisamy A, Stratta R.. Transplantation. 2014;98(Suppl 1):855.

Pancreas transplantation in C-peptide positive patients: does type of diabetes really matter? [abstract]. Bodner J, Farney A, Rogers J, Orlando G, Farooq U, Al-Shraideh Y, Reeves-Daniel A, Palanisamy A, Stratta R.. Transplantation. 2014;98(Suppl 1):864.

7 year results of a prospective randomized study of alemtuzumab vs rabbit anti-thymocyte globulin induction in kidney and kidney pancreas transplantation [abstract]. Farney A, Rogers J, Doares W, Iskandar S, Orlando G, Adams P, Gautreaux M, Kaczmorski S, Stratta R.. Transplantation. 2014;98(Suppl 1):90.

ECM scaffolds from discarded human kidneys perform as bio-system when seeded with multipotent progenitor cells [abstract]. Orlando G, Sedrakyan S, Peloso A, Wang Z, Farney A, Delario G, Rogers J, Stratta R, Soker S, Perin L.. Transplantation. 2014;98(Suppl 1):304.

ECM scaffolds from discarded human kidneys retain growth factors along with intact microstructural morphologies of the innate vasculature [abstract]. Peloso A, Katari R, Booth C, Wang Z, Zambon J, Farney A, Rogers J, Delario G, Stratta R, Soker S, Orlando G.. Transplantation. 2014;98(Suppl 1):304.

Pancreas transplantation in African American compared to non African American patients: does recipient ethnicity influence outcomes? [abstract]. Rogers J, Farney A, Orlando G, Farooq U, Al-Shraideh Y, Reeves-Daniel A, Palanisamy A, Bodner J, Stratta R.. Transplantation. 2014;98(Suppl 1):864.

Similar results with solitary pancreas transplantation compared to simultaneous pancreas-kidney transplantation in the new millennium [abstract]. Rogers J, Farney A, Orlando G, Farooq U, Al-Shraideh Y, Reeves-Daniel A, Palanisamy A, Iskandar S, Gautreaux M, Doares W, Kaczmorski S, Stratta R.. Transplantation. 2014;98(Suppl 1):854.

Does donor ethnicity influence kidney transplant outcome after simultaneous kidney-pancreas transplantation? [abstract]. Rogers J, Farney A, Orlando G, Reeves-Daniel A, Palanisamy A, Farooq U, Al-Shraideh Y, Winfrey S, Uloko V, Bodner J, Doares W, Kaczmorski S, Gautreaux M, Iskandar S, Freedman B, Stratta R.. Transplantation. 2014;98(Suppl 1):861.

Osseus metaplasia in kidney allografts as a paradigm of regenerative medicine principles. Sanders BP, Orlando G, Peloso A, Katari RS, Iskandar SS, Farney AC, Rogers J, Soker S, Stratta RJ.. Exp Clin Transplant. 2014;12(4):371-373.

Single center analysis of mortality in 202 consecutive pancreas transplants [abstract]. Stratta R, Farney A, Orlando G, Farooq U, Al-Shraideh Y, Reeves-Daniel A, Palanisamy A, Bodner J, Rogers J.. Transplantation. 2014;98(Suppl 1):860.

What we do and don't understand about pancreas graft failure [abstract]. Stratta R, Farney A, Orlando G, Farooq U, Al-Shraideh Y, Reeves-Daniel A, Palanisamy A, Bodner J, Rogers J.. Transplantation. 2014;98(Suppl 1):863.

Expanded criteria donors: the end of an era [abstract]. Stratta R, Farney A, Orlando G, Farooq U, Al-Shraideh Y, Reeves-Daniel A, Palanisamy A, Gautreaux M, Iskandar S, Doares W, Kaczmorski S, Mangus M, Rogers J.. Transplantation. 2014;98(Suppl 1):654.

Experience with deceased donor kidney transplantation in 114 septuagenarians [abstract]. Stratta R, Farney A, Orlando G, Farooq U, Al-Shraideh Y, Reeves-Daniel A, Palanisamy A, Iskandar S, Gautreaux M, Rogers J.. Transplantation. 2014;98(Suppl 1):600.

5 year results of a prospective, randomized single center study of alemtuzumab compared to rabbit anti-thymocyte gobulin induction in simultaneous kidney-pancreas transplantation [abstract]. Stratta R, Rogers J, Orlando G, Farooq U, Al-Shraideh Y, Doares W, Kaczmorski S, Reeves-Daniel A, Palanisamy A, Farney A.. Transplantation. 2014;98(Suppl 1):215.

Dual kidney transplants from adult marginal donors: double or nothing [abstract]. Stratta R, Rogers J, Orlando G, Farooq U, Al-Shraideh Y, Reeves-Daniel A, Palanisamy A, Iskandar S, Gautreaux M, Farney A.. Transplantation. 2014;98(Suppl 1):595-596.

All Publications

For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.

For a list of earlier publications, visit the Carpenter Library Publication Search.

Professor, Surgical Sciences-Transplant

Clinical Interests

Kidney Transplantation, Pancreas Transplantation
Alan C. Farney, M.D.

Alan C. Farney, M.D.

Professor, Surgical Sciences-Transplant
Institute for Regenerative Medicine

Doctor Rating

4.7 out of 5

Alan C. Farney, M.D.54 Ratings
7 Comments


 

Doctor Ratings

The overall Patient Rating score is the average of responses to the nine questions listed below. The questions are from the Press Ganey Patient Satisfaction Survey. Responses are measured on a 1 to 5 scale, where 1 represents "very poor" and 5 represents "very good."
Press Ganey Patient Satisfaction Survey

CP concern for questions/worries
4.8
CP efforts to include in decisions
4.7
CP explanations of prob/condition
4.8
CP spoke using clear language
4.8
Friendliness/courtesy of CP
4.7
Likelihood of recommending CP
4.7
Patients' confidence in CP
4.7
Time CP spent with patient
4.7
Wait time at clinic
4.0



Patient Comments

Comments are taken from the Care Provider section of the Press Ganey Patient Satisfaction Survey. Comments are posted exactly as they are written. Comments are added weekly. To protect patient privacy and confidentiality, patient names are not included.

4/28/2016

very attentive

3/23/2016

*Dr. Farney created a great visit and went the extra mile to assist with an issue. Extremely helpful, particularly with how busy they are.

2/26/2016

Always very good as if I was their only patient.

11/10/2015

Great job.

10/27/2015

dr spent good amount of timeexplaining problem and talking about future

10/2/2015

So far it has been perfect. We love the Dr.'s PA's & NP's!

9/22/2015

Excellent.

Quick Reference

Request an Appointment
New Patients

336-716-WAKE
888-716-WAKE

Existing patients may contact the clinic directly.
Find a Doctor Ways to Give
Magnet Hospital RecognitionConsumer Choice2015 Best DoctorsJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.